Becattini C, Bauersachs R, Maraziti G, Bertoletti L, Cohen A, Connors JM, Manfellotto D, Sanchez A, Brenner B, Agnelli G. Renal function and clinical outcome of patients with cancer-associated venous thromboembolism randomized to receive apixaban or dalteparin. Results from the Caravaggio trial. haematol [Internet]. 2022Jul.1 [cited 2024Dec.26];107(7):1567-76. Available from: https://haematologica.org/article/view/haematol.2021.279072